Akèy › Asm
Etid klinik pou Asm ap rekrite nan Etazini
97 etid pou Asm ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Miami, FL12 etid
- New York City, NY11 etid
- Boston, MA11 etid
- Oklahoma City, OK10 etid
- Durham, NC10 etid
- Dallas, TX10 etid
- Washington, DC9 etid
- The Bronx, NY9 etid
- Kansas City, KS8 etid
- Houston, TX8 etid
- St. Louis, MO7 etid
- Cincinnati, OH7 etid
- Pittsburgh, PA7 etid
- Tampa, FL7 etid
- Charlotte, NC7 etid
- Aurora, CO7 etid
- San Antonio, TX6 etid
- Colorado Springs, CO6 etid
- Philadelphia, PA5 etid
- Cleveland, OH5 etid
- Austin, TX5 etid
- Toledo, OH5 etid
- Ann Arbor, MI5 etid
- Baltimore, MD5 etid
- McKinney, TX5 etid
- San Jose, CA5 etid
- Evansville, IN5 etid
- Orlando, FL5 etid
- El Paso, TX4 etid
- Milwaukee, WI4 etid
- Omaha, NE4 etid
- Phoenix, AZ4 etid
- San Diego, CA4 etid
- Long Beach, CA4 etid
- Nashville, TN4 etid
- Atlanta, GA4 etid
- Denver, CO4 etid
- Hialeah, FL4 etid
- Los Angeles, CA4 etid
- Columbia, MO4 etid
Pa eta
- Alabama6 etid
- Arizona8 etid
- Colorado18 etid
- Distrik Columbia3 etid
- Florid25 etid
- Georgia7 etid
- Illinois10 etid
- Indiana4 etid
- Kalifòni23 etid
- Kansas10 etid
- Kentucky7 etid
- Lwizyàn5 etid
- Maryland10 etid
- Massachusetts15 etid
- Michigan10 etid
- Missouri11 etid
- Nebraska5 etid
- Nevada5 etid
- New Jersey8 etid
- New York23 etid
- North Carolina16 etid
- Ohio14 etid
- Oklahoma10 etid
- Oregon4 etid
- Pennsylvania11 etid
- South Carolina9 etid
- South Dakota3 etid
- Tennessee4 etid
- Texas20 etid
- Utah4 etid
- Virginia5 etid
- Wisconsin7 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07645248A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT05757102A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
Ap rekriteFaz 3
Laj 12 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT07782996Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Ap rekriteEtid obsèvasyon
Laj 1 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001406Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06932263A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-1)
Ap rekriteFaz 3
Laj 12 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT07780643ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT07301255Microglia Activation in Asthma
Ap rekriteEtid obsèvasyon
Laj 18 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT04307667Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT01143480Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Ap rekriteFaz 3
Laj 6 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07444567A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07219173A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Ap rekriteFaz 3
Laj 12 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07359846A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 22, 2026 · NCT06977581A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Ap rekriteFaz 3
Laj 5 a 11 · Tout sèks · Mizajou Sep 21, 2026 · NCT06023589A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Ap rekriteFaz 3
Laj 12 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07276724Resources and Education for Addressing Chronic Health (REACH)
Ap rekrite
Laj 3 a 18 · Tout sèks · Mizajou Sep 21, 2026 · NCT07819747QUARTZ: Comparative Effectiveness of Switching From Albuterol to Albuterol/Budesonide Versus Adding Low-dose ICS or LTRA to Albuterol
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Sep 18, 2026 · NCT07787117PULmonary Stimulation for Asthma Relief
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Sep 16, 2026 · NCT07709754Personalized Environment and Genes Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Tout sèks · Mizajou Sep 16, 2026 · NCT00341237Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07396987Role of Genetic Factors in the Development of Lung Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 90 · Tout sèks · Mizajou Sep 10, 2026 · NCT00001532CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
Ap rekriteFaz 4
Laj 12 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07241117ASTHMAXcel Voice Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06935084A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 2, 2026 · NCT07660731NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
Ap rekriteEtid obsèvasyon
Laj 18 a 60 · Tout sèks · Mizajou Sep 1, 2026 · NCT02327897Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.